U.S. Markets close in 5 hrs 11 mins

The 76ers issued an encouraging and confusing health update on Markelle Fultz

Markelle Fultz has played just 76 minutes for the 76ers. (AP)

The Philadelphia 76ers issued yet another update on the status of rookie Markelle Fultz’s injured right shoulder, and your guess is as good as ours as to what it means for his potential return this season.

“Philadelphia 76ers guard Markelle Fultz has been cleared to begin the final stage of his return-to-play program,” the team said. “The program consists of gradual re-integration into team practices and training, complemented with additional conditioning work to support readiness for gameplay.”

This comes nine weeks after the Sixers shut Fultz down with “scapular muscle imbalance,” six weeks after the team announced Fultz’s “return to gameplay will be determined by how the shoulder responds to progressive basketball training and practices” over a two- to three-week period, a month after the team said its No. 1 overall pick’s shoulder soreness is “completely gone” and a week after 76ers coach Brett Brown described his activity thusly, via NBC Sports Philadelphia’s Jessica Camerato:

“[He] continued to work on his movement, trying to build his conditioning, trying to continue to strengthen his shoulder. Slowly moving him to trying to play at a pace and a speed that is more game-like to test it and also grow his fitness base.”

Given the team’s vague injury timelines for lottery picks Nerlens Noel, Jahlil Okafor, Joel Embiid and Ben Simmons over the past five years, it surprises nobody that Fultz is taking much longer to return than the Sixers originally indicated in training camp and that the latest “update” offers no reason to believe “the final stage of his return-to-play program” will be anything short of a prolonged absence.

At least when the Sixers opened the curtain on Tuesday’s practice, Fultz could be seen by reporters shooting with his right hand, which is more than could be said in early November, when the media captured him attempting jumpers with his left hand, revealing the severity of his shoulder injury.



“He came out and participated in some 4-on-4 halfcourt stuff with his team, and now you’re seeing what you’re seeing, some light 1-on-1 stuff,” Brown told reporters of Fultz on Tuesday, via the Philly Voice. “The reality of the whole thing is, the more you feel the team and coach the team, his skillset ties so many things together. He can make plays. When you are missing some of those qualities in a group, things get exposed. He can create a shot for himself, and he can create a shot for others.”

The 4-on-4 news is undoubtedly positive, as is just the sight of Fultz putting in work at a practice. And, yes, Fultz was considered a transcendent talent coming out of the University of Washington. Plus, Philadelphia’s trade of two high-end draft picks to take him at No. 1 signaled to the city that the core of Fultz, Simmons and Embiid would finally be the culmination of a half-decade-long tanking process.

Fultz entered the league as a dynamic modern point guard, capable of both playmaking on Embiid pick-and-rolls and scoring off Simmons drive-and-kicks. He has since played just 76 minutes.

A hot start for Simmons and Embiid helped mask Fultz’s absence in the first month of the season, as the 76ers moved to as many as four games above .500 at the start of last month, but they’ve since fallen as many as four games below even, and they now sit in 10th place in the Eastern Conference, a game and a half out of the final playoff spot.

They could use an injection of what Fultz was supposed to be, and not just for basketball reasons. (They owned a bottom-10 offense in the month of December.) From the top of the first round (Jayson Tatum) to the middle (Donovan Mitchell) and even the bottom (Kyle Kuzma), the 2017 NBA Draft has been one of the most successful first-year classes in recent memory, all of which has made the absence of Fultz even more frustrating for a Philadelphia fan base that keeps being told to be patient.

And from the sound of this latest status update, they’ll still have to wait a little longer.

– – – – – – –

Ben Rohrbach is a contributor for Yahoo Sports. Have a tip? Email him at rohrbach_ben@yahoo.com or follow him on Twitter!

  • Is Viper Energy Partners (VNOM) Stock Outpacing Its Oils-Energy Peers This Year?
    Business
    Zacks

    Is Viper Energy Partners (VNOM) Stock Outpacing Its Oils-Energy Peers This Year?

    The Oils-Energy group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Viper Energy Partners is a member of the Oils-Energy sector. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

  • Sears bankruptcy could make these 5 big companies multi-million-dollar losers
    Finance
    Yahoo Finance

    Sears bankruptcy could make these 5 big companies multi-million-dollar losers

    Signs advertising store closing sales are seen on the doors of a Sears in New Hyde Park, New York, U.S., October 10, 2018. REUTERS/Shannon Stapleton Being an unsecured creditor of Sears (SHLD) right now is not a good place to be. The 125-year old former

  • Business
    Benzinga

    Insider Buys Of The Week: Conagra, Salesforce, Thor

    Conventional wisdom says insiders and 10 percent owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. While the board chair and other Salesforce.com, inc. (NYSE: CRM) executives have been selling throughout October, one director stepped up to the buy window this past week. The stock ended Friday at $146.74, down more than 4 percent for the week, and above the director's purchase price range.

  • Finance
    Bloomberg

    Tesla Skeptic Surprised by How Much He Enjoyed the Model 3

    In a broader note about positive electric-car momentum, Jonas said he observed workers at Tesla’s lone auto plant in Fremont, California, who were “extremely busy cranking out Model 3s” for delivery in the U.S. He also drove the dual-motor performance version of the vehicle, which he sees as having better value-for-performance than the Model S sedan. “Frankly, our enjoyment of the high-spec version of the Model 3 took us by surprise,” Jonas said, adding that it’s “hard to say how much this matters.

  • Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession
    News
    Time

    Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession

    Prince Harry and Meghan Markle are expecting a baby in spring 2019, Kensington Palace announced Monday morning. Harry and Meghan married in May, becoming the Duke and Duchess of Sussex. Now, the question is where the new arrival will fit into the line of succession of the British royal family.

  • This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning
    Business
    Motley Fool

    This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning

    Investors have never been more excited about the prospects for marijuana stocks, and many of the best-known first movers in the industry call Canada their home. Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) is one of the major companies in the cannabis industry looking to cash in on the impending legalization of recreational marijuana in Canada, and it's put together an impressive set of resources designed to let it take maximum advantage of growing consumer interest in cannabis products. Like most up-and-coming companies, Aurora Cannabis isn't consistently profitable, and the marijuana producer is spending freely to ramp up its production capabilities to stay ahead of competitors.

  • This Is the Average American's Salary. How Does Yours Compare?
    Business
    Motley Fool

    This Is the Average American's Salary. How Does Yours Compare?

    In an age of oversharing, many of us are remarkably tight-lipped when it comes to talking salary. But in reality, knowing where you stand can help you determine whether you're in a good place or whether you should be taking steps to boost your earnings

  • 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better
    Business
    Motley Fool

    2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better

    During a tough week for the overall market, pharmaceutical stocks across the board fell a few notches despite a lack of significant news for the industry itself. Over the past five years, Pfizer has been able to raise its dividend 42% despite declining sales for aging blockbusters that lost patent protection and a sterile injectibles business that suffered major product shortages after it was acquired. Now that the worst is over, a strong product lineup and bulging pipeline could allow America's largest pharmaceutical company to direct a ton of cash toward its shareholders.

  • Tesla Model 3 hits major milestone
    TSLA
    Fox Business Videos

    Tesla Model 3 hits major milestone

    FBN's Cheryl Casone on Tesla reaching a milestone of 100,000 Model 3 vehicles and Tesla CEO Elon Musk filing the paperwork to create a Tesla brand tequila called 'Teslaquila.'

  • Microsoft Earnings: Mark Your Calendar
    Business
    Motley Fool

    Microsoft Earnings: Mark Your Calendar

    Software giant Microsoft (NASDAQ: MSFT) has continued to impress investors in 2018 amid its ongoing progress becoming a more cloud-centric company. Microsoft reports its first-quarter earnings for fiscal 2019 on October 24. Ahead of Microsoft's earnings release, here's an overview of some of the key areas investors will want to watch. Core to Microsoft's momentum recently is the company's rapidly growing commercial-cloud revenue.

  • September Aircraft Orders: Boeing Beats Airbus Again
    Business
    Motley Fool

    September Aircraft Orders: Boeing Beats Airbus Again

    Thus far, 2018 has been a great year for Boeing (NYSE: BA) in terms of aircraft orders. Meanwhile, Airbus (NASDAQOTH: EADSY) had another quiet month, allowing Boeing to extend its lead in the annual order race. During the first eight months of 2018, Boeing captured 581 net firm orders for commercial jets.

  • Why I’m Not Worried About Being Behind on Retirement Savings
    Business
    GoBankingRates

    Why I’m Not Worried About Being Behind on Retirement Savings

    This is why I find it funny that we spend most of our lives “retirement planning” or planning for our deaths. Don’t get me wrong, I’m not shouting in the face of retirement planning or being prepared. Although I’ve gotten my life back on track since then, I’m still not worried about being behind on retirement savings, the magical “$1 million saved” for retirement number or all the “what ifs.” Why?

  • BofA Stung by Shadow Banks as Investment-Banking Fees Slip
    Finance
    Bloomberg

    BofA Stung by Shadow Banks as Investment-Banking Fees Slip

    While analysts had expected the firm to lose share to rivals in advisory fees, BofA also posted a 29 percent decline in debt-underwriting revenue, almost twice the drop that had been estimated. BofA’s income from leveraged finance was pinched by regulatory constraints and increased competition from nonbank lenders, sometimes known as shadow banks, Chief Financial Officer Paul Donofrio said on a call with journalists Monday. The firm’s investment bank has also been grappling with a string of senior-level departures this year, including the exit of the business’s head, Christian Meissner.

  • Ford Escape sales are down — here’s how it compares with other small SUVs
    Business
    American City Business Journals

    Ford Escape sales are down — here’s how it compares with other small SUVs

    Sales of the Ford Escape aren't what they used to be. The Escape, made at the Louisville Assembly Plant, saw sales decline by 20 percent in September 2018, compared with the same month last year. Ford and its Lincoln Motor Co. subsidiary have been successful in increasing sales of larger SUVs, such as the Navigator and Expedition this year.

  • Jack Bogle's Stock and Bond Market Return Expectations
    Business
    Morningstar

    Jack Bogle's Stock and Bond Market Return Expectations

    The Vanguard founder says low dividend yields, modest earnings growth potential, and still-low rates mean returns are set to be lower.

  • What Investors Should Know about AT&T’s Growth Prospects
    Business
    Market Realist

    What Investors Should Know about AT&T’s Growth Prospects

    What Investors Should Know about AT&T’s Growth Prospects AT&T’s earnings in Q3 2018 AT&T (T), the second-largest wireless service provider in the United States, is looking to showcase its strength as it nears its third-quarter earnings release. The company

  • Better Marijuana Stock: Canopy Growth Corporation vs. Aphria Inc.
    Business
    Motley Fool

    Better Marijuana Stock: Canopy Growth Corporation vs. Aphria Inc.

    Recreational marijuana sales begin on Oct. 17 in Canada, and investors convinced the program will be a hit have pushed shares of Canopy Growth Corporation (NYSE: CGC) and Aphria Inc. (NASDAQOTH: APHQF) up by 60% or better over the past few months. In just two short years, Canopy Growth Corporation's market cap has exploded from just $476 million two years ago to $10.1 billion at recent prices, and it looks like there could be more fireworks ahead. Canopy Growth has secured contracts that will require it to provide at least 67,000 kilograms of cannabis annually to Canadian provinces and territories.

  • Business
    Benzinga

    Bulls & Bears Of The Week: GE, Netflix, Nike, Twitter And More

    Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included an old-school conglomerate and a social media pair. Bearish calls included an electric car maker and a pharmaceutical firm. Another major hurricane

  • 2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?
    Business
    Motley Fool

    2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?

    Two marijuana stocks that are currently listed on Canadian stock exchanges soon plan also to list on U.S. stock exchanges. Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) expects to trade on the New York Stock Exchange (NYSE) by the end of October and Aleafia Health (NASDAQOTH: ALEAF) should soon trade on the Nasdaq stock exchange. Are these hot marijuana stocks that are coming soon to U.S. stock exchanges smart picks to buy now?

  • Short Sellers Missed Tencent’s $250 Billion Party
    Business
    Bloomberg

    Short Sellers Missed Tencent’s $250 Billion Party

    Assuming the shares fall enough and borrowing costs aren’t too high, a short seller can make a tidy profit while other investors lose money. Except if that company is Tencent Holdings Ltd. Less than 0.3 percent of all outstanding shares in Tencent are shorted, according to data compiled by Markit.

  • It’s Official -- These 5 Social Security Changes Are Coming for 2019
    Business
    Motley Fool

    It’s Official -- These 5 Social Security Changes Are Coming for 2019

    For workers, Social Security's maximum taxable earnings are increasing, and more income will be required to earn a Social Security "credit." Beneficiaries who claimed Social Security early and still work will be happy to learn they'll be able to earn more without a benefit reduction in 2019, and for high earners, the maximum possible Social Security benefit is also on the rise. With all of that in mind, here are the recently released details of these five 2019 Social Security changes. As I mentioned, Social Security beneficiaries are getting a 2.8% COLA starting with their January 2019 benefit payment.

  • Will Procter & Gamble Start Its New Fiscal Year on the Right Foot?
    Business
    Motley Fool

    Will Procter & Gamble Start Its New Fiscal Year on the Right Foot?

    Procter & Gamble (NYSE: PG) is less than a week away from its first earnings report of a new fiscal year, and shareholders are hoping for better results than what it delivered the previous two quarters, which were marked by sluggish sales growth that missed management's targets. P&G has been working to end a stubborn period of modest market share losses for several of its core franchises. Organic sales growth, which measures core revenue growth by factoring out exchange rate shifts and brand acquisitions, slowed to a 1% rate over the prior 12 months from 2% in fiscal 2017.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Business
    Motley Fool

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    One is market cap: Aurora's market cap is nearly 18 times bigger than Auxly's. Then there's stock performance. Here's how Aurora Cannabis and Auxly Cannabis Group stack up against each other in the areas that do matter.

  • News
    CNBC

    He retired at 34. Here's how many people are enjoying a very early retirement

    Retiring in your 60s and 70s can seem a challenge to pull off. A few early retirees break down how they did it. Retiring comfortably in yours 60s or 70s can seem a high-wire act, so how are some people pulling it off without a wrinkle in their face?

  • Is This High-Flying Marijuana Stock the Next Tilray?
    Business
    Motley Fool

    Is This High-Flying Marijuana Stock the Next Tilray?

    Since then, Tilray's share price has skyrocketed to well over six times its opening-day level. At one point, Tilray was up a whopping 856% -- in just two months of trading. Now there's another marijuana stock that is beginning to turn heads.